scholarly journals Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization

2017 ◽  
Vol 31 (2) ◽  
pp. 99-105 ◽  
Author(s):  
Tariq Al-Debasi ◽  
Abdulkareem Al-Bekairy ◽  
Abdulmalik Al-Katheri ◽  
Shmeylan Al Harbi ◽  
Mahmoud Mansour
Sign in / Sign up

Export Citation Format

Share Document